SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ipca Laboratories - Quaterly Results

13 Aug 2024 Evaluate
The revenue zoomed 5.35% to Rs. 15658.60 millions for the quarter ended June 2024 as compared to Rs. 14863.40 millions during the corresponding quarter last year.Modest increase of 22.54% in the Net Profit was reported from. 1665.80 millions to Rs. 2041.30  millions.OP of the company witnessed a marginal growth to 3686.30 millions from 3408.90 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 15658.60 14863.40 5.35 15658.60 14863.40 5.35 61664.60 58146.20 6.05
Other Income 153.90 431.60 -64.34 153.90 431.60 -64.34 1112.90 1111.90 0.09
PBIDT 3686.30 3408.90 8.14 3686.30 3408.90 8.14 13226.70 10230.40 29.29
Interest 194.20 307.60 -36.87 194.20 307.60 -36.87 1206.70 439.20 174.75
PBDT 3492.10 3099.30 12.67 3492.10 3099.30 12.67 10686.40 9791.20 9.14
Depreciation 613.20 603.50 1.61 613.20 603.50 1.61 2464.80 2286.30 7.81
PBT 2878.90 2495.80 15.35 2878.90 2495.80 15.35 8221.60 7504.90 9.55
TAX 837.60 830.00 0.92 837.60 830.00 0.92 2917.50 2447.90 19.18
Deferred Tax 27.60 30.00 -8.00 27.60 30.00 -8.00 37.40 208.40 -82.05
PAT 2041.30 1665.80 22.54 2041.30 1665.80 22.54 5304.10 5057.00 4.89
Equity 253.70 253.70 0.00 253.70 253.70 0.00 253.70 253.70 0.00
PBIDTM(%) 23.54 22.93 2.65 23.54 22.93 2.65 21.45 17.59 21.91

Ipca Laboratories Share Price

1551.15 7.20 (0.47%)
06-May-2026 10:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1829.90
Dr. Reddys Lab 1291.95
Cipla 1346.30
Zydus Lifesciences 925.60
Lupin 2395.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×